These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7408392)

  • 1. Effect of prazosin on renal function in congestive heart failure.
    Pierpont GL; Franciosa JA; Cohn JN
    Clin Pharmacol Ther; 1980 Sep; 28(3):335-9. PubMed ID: 7408392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of low dose prazosin in patients with congestive heart failure.
    Lang CC; Choy AM; Rahman AR; Struthers AD
    Eur Heart J; 1993 Sep; 14(9):1245-52. PubMed ID: 8223740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in heart failure after prazosin.
    Ogasawara B; Ogawa K; Hayashi H; Sassa H
    Clin Pharmacol Ther; 1981 Apr; 29(4):464-71. PubMed ID: 6258839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril on renal function in patients with congestive heart failure.
    Pierpont GL; Francis GS; Cohn JN
    Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prazosin on renal function in chronic congestive cardiac failure.
    Myers JB; Morgan TO; Walker JN
    Med J Aust; 1981 Sep; 2(6):290-1. PubMed ID: 7300762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
    Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA
    Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in blood viscosity concomitant with prazosin therapy in patients with essential arterial hypertension].
    Letcher RL; Chien S; Laragh JG
    Cardiology; 1980; 66 Suppl 2():12-25. PubMed ID: 6269739
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.
    Horowitz JD; Dynon MK; Jarrott B; Brennan JB; Oliver LE; Goble AJ; Louis WJ
    Clin Exp Pharmacol Physiol; 1984; 11(1):7-15. PubMed ID: 6713738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of diltiazem hydrochloride upon sodium diuresis and renal function in chronic congestive heart failure.
    Kinoshita M; Kusukawa R; Shimono Y; Motomura M; Tomonaga G; Hoshino T
    Arzneimittelforschung; 1979; 29(4):676-81. PubMed ID: 582767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of congestive heart failure on prazosin kinetics.
    Jaillon P; Rubin P; Yee YG; Ball R; Kates R; Harrison D; Blaschke T
    Clin Pharmacol Ther; 1979 Jun; 25(6):790-4. PubMed ID: 445945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prazosin on forearm resistance and capacitance vessels.
    Awan NA; Miller RR; Maxwell K; Mason DT
    Clin Pharmacol Ther; 1977 Jul; 22(1):79-84. PubMed ID: 872499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.